VivoSim Labs, Inc. Restructuring Charges
VivoSim Labs, Inc. (VIVS) reported Restructuring Charges of $0 for the 3-month period ending 2023-12-31, per its 10-Q filed 2024-02-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RestructuringCharges · last filed 2024-02-08
- VivoSim Labs, Inc. restructuring charges for the quarter ending 2023-12-31 was $0.00.
- VivoSim Labs, Inc. restructuring charges for the quarter ending 2023-09-30 was $0.00.
- VivoSim Labs, Inc. restructuring charges for the quarter ending 2020-12-31 was $0.00, a 100.00% decline year-over-year.
- VivoSim Labs, Inc. restructuring charges for the quarter ending 2020-09-30 was $2.81M, a 14.33% increase year-over-year.
| Period end | Restructuring Charges 3 month | Restructuring Charges 3 month as first filed | Restructuring Charges 6 month | Restructuring Charges 9 month | Restructuring Charges 9 month as first filed |
|---|---|---|---|---|---|
| 2023-12-31 | $0.00 10-Q · filed 2024-02-08 | $0.00 derived: sum of 2 quarters · filed 2024-02-08 | $380.00K 10-Q · filed 2024-02-08 | ||
| 2023-09-30 | $0.00 10-Q · filed 2024-02-08 | $380.00K 10-Q · filed 2023-11-09 | |||
| 2020-12-31 | $0.00 10-Q · filed 2021-02-08 | $2.81M derived: sum of 2 quarters · filed 2021-02-08 | $2.81M 10-Q · filed 2021-02-08 | ||
| 2020-09-30 | $2.81M 10-Q · filed 2020-11-05 | $2.81M 10-Q · filed 2020-11-05 | |||
| 2020-06-30 | $0.00 10-Q · filed 2020-08-10 | ||||
| 2019-12-31 | $341.00K 10-Q · filed 2021-02-08 | $2.80M derived: sum of 2 quarters · filed 2021-02-08 | $2.80M 10-Q · filed 2021-02-08 | $2.46M 10-Q · filed 2020-02-10 | |
| 2019-09-30 | $2.46M 10-Q · filed 2020-11-05 | $2.46M 10-Q · filed 2020-11-05 | |||
| 2019-06-30 | $0.00 10-Q · filed 2020-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |